This inventor holds 1 USPTO granted patent. Top assignee: Principia Biopharma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sebastien Roy: Inventor in Pharmaceutical Research.
Introduction
Sebastien Roy is an inventor associated with Sermaise, France, and Principia Biopharma Inc. His patent work concerns a class of chemical compounds described for potential use as agonists and antagonists.
Latest Patents
Roy is named on 1 patent: “4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one derivatives and salts thereof.” The disclosure covers variants and derivatives of these compounds, their salts, compositions containing them, methods for preparing them, and methods of treatment.
Career Highlights
Roy’s listed patent reflects work in pharmaceutical innovation, particularly the development of compounds with potential therapeutic applications. The available information identifies Principia Biopharma Inc. as the company with which he is associated.
Collaborations
Catherine Arabeyre and Patricia Moliner are identified as Roy’s coworkers. Their names are also associated with the collaborative context of his patent work.
Conclusion
Sebastien Roy’s recorded invention focuses on pharmaceutical compounds and their potential uses, making his patent contribution part of research into therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile